Asthma

Menu

Asthma

Progression

  • When did disease process start
  • Initial versus subsequent visit

Location

  • N/A

Acuity

  • Mild intermittent, mild persistent, moderate persistent, severe persistent
    Severe Persistent
    • Continual symptoms
    • Limited physical activity
    • Frequent exacerbations
    • Nighttime symptoms frequent
    • FEV1 or PEF  ≤ 60% predicted
    • PEF variability > 30% 

    Moderate persistent
    • Daily symptoms
    • Daily use of inhaled short-acting beta2-agnostic
    • Exacerbation of affect activity
    • Exacerbation ≥ 2 times/week ≥ 1 day(s)
    • Nighttime symptoms > 1 time/ week
    • FEV1 or PEF 60-80% predicted
    • PEF variability > 30% 

    Mild persistent
    • Symptoms > 2 times/week but < 1 time/day
    • Exacerbation may affect activity
    • Nighttime symptoms > 2 times/ month
    • FEV1 or PEF ≥ 80% predicted
    • PEF variability 20-30% 

    Mild intermittent
    • Symptoms ≤ 2 times/week
    • Asymptomatic and normal PEF between exacerbations
    • Exacerbations of varying intensity are brief (a few hours to a few days)
    • Nighttime symptoms ≤ 2 times/ month
    • FEV1 or PEF ≥ 80% predicted
    • PEF variability < 20% 

  • With status asthmaticus (intractable, refractory)

Name

  • Intrinsic asthma (nonallergenic)
  • Uncomplicated with acute exacerbation

Necessary Procedures

  • Interventions used to stabilize patient (nebulizers, inhalers, bronchodilators, etc.)

Other

  • Exposure to tobacco

Why

  • Any known causes or underlying conditions, comorbidities, associated problems (bronchiolitis, bronchiectasis), abnormal vitals, underdosing of medications, change in medications, smoking, etc.